gptkbp:instanceOf
|
gptkb:Company
|
gptkbp:acquisition
|
gptkb:Daiichi_Sankyo
2008
$4.6 billion
|
gptkbp:awards
|
Yes
|
gptkbp:CEO
|
gptkb:Shivinder_Mohan_Singh
gptkb:Malvinder_Mohan_Singh
|
gptkbp:challenges
|
Yes
|
gptkbp:clinicalTrials
|
Yes
|
gptkbp:competitors
|
gptkb:Aurobindo_Pharma
gptkb:Cipla
gptkb:Lupin_Pharmaceuticals
gptkb:Sun_Pharmaceutical_Industries
gptkb:Dr._Reddy's_Laboratories
|
gptkbp:corporateSocialResponsibility
|
Yes
|
gptkbp:employees
|
over 10,000
|
gptkbp:founded
|
1961
|
gptkbp:founder
|
gptkb:B._D._Sanghvi
|
gptkbp:globalPresence
|
Yes
|
gptkbp:headquarters
|
gptkb:Haryana,_India
gptkb:India
gptkb:Gurgaon
gptkb:Gurgaon,_India
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ranbaxy Laboratories Limited
|
gptkbp:industry
|
pharmaceuticals
|
gptkbp:market
|
$3.2 billion (2013)
|
gptkbp:marketSegment
|
Yes
|
gptkbp:operatingHours
|
$200 million (2013)
|
gptkbp:pairing
|
Yes
|
gptkbp:parentCompany
|
gptkb:Daiichi_Sankyo_Company,_Limited
|
gptkbp:partnerships
|
Yes
|
gptkbp:patentCitation
|
Yes
|
gptkbp:productionCompany
|
Yes
|
gptkbp:products
|
antibiotics
generic drugs
oncology drugs
cardiovascular drugs
respiratory drugs
diabetes medications
dermatological products
gastrointestinal drugs
pain management drugs
hormonal drugs
anti-retrovirals
|
gptkbp:regulatoryCompliance
|
Yes
|
gptkbp:research_areas
|
Yes
|
gptkbp:researchAndDevelopment
|
Yes
|
gptkbp:revenue
|
$1.5 billion (2013)
|
gptkbp:stockExchange
|
gptkb:BSE
NSE
|
gptkbp:subsidiary
|
gptkb:Ranbaxy_USA_Inc.
gptkb:Ranbaxy_Pharmaceuticals_Inc.
gptkb:Ranbaxy_(UK)_Limited
|
gptkbp:sustainabilityInitiatives
|
Yes
|
gptkbp:website
|
www.ranbaxy.com
|